| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.23 | 0.1 |